35 results
Page 2 of 2
6-K
EX-99.2
fntuks
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
6-K
EX-99.3
xmagfqwlh0wh0cgawn
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
6-K
EX-99.1
c0828ox
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
6-K
EX-99.2
4wlhh7xhyzsby07y jnr
3 Jun 21
Development program exploring the potential of CBP-174 in the treatment of chronic inflammatory pruritus
6:04am
424B4
dsuaj5ocab3589pnnf
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
8en0p
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
q5w2 xct1z
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-99.1
m1lprapl 8gxd
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
CORRESP
fjb8vtksj smusd
8 Mar 21
Correspondence with SEC
12:00am
F-1
EX-10.10
hjrwl9zaqamu1y1qj
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.15
0zin1tl 44j
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
xj2rivflonxf7i4z
26 Feb 21
Registration statement (foreign)
4:56pm
DRS/A
pjds4d
26 Jan 21
Draft registration statement (amended)
12:00am
DRS
f0j41j5xn8oj0lli
17 Dec 20
Draft registration statement
12:00am
DRS
EX-10.7
qu6vzxb62
17 Dec 20
Draft registration statement
12:00am